GUARDANT HEALTH, INC. Tax Withholding Paid on Stock Awards
GUARDANT HEALTH, INC. (GH) reported Tax Withholding Paid on Stock Awards of $28.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $8.32M, a 12.10% increase year-over-year.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $20.65M, a 33.25% increase year-over-year.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $5.35M, a 33.29% decline year-over-year.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $2.27M, a 21.19% decline year-over-year.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $30.54M, a 94.73% increase from fiscal 2024.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $15.68M, a 40.05% increase from fiscal 2023.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $11.20M, a 42.13% increase from fiscal 2022.
- GUARDANT HEALTH, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $7.88M, a 90.59% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $28.97M 10-Q · filed 2026-07-30 | $34.32M derived: sum of 3 quarters · filed 2026-07-30 | $36.59M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $20.65M 10-Q · filed 2026-05-07 | $26.00M derived: sum of 2 quarters · filed 2026-05-07 | $28.27M derived: sum of 3 quarters · filed 2026-05-07 | $35.69M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.62M derived: sum of 2 quarters · filed 2026-02-19 | $15.04M derived: sum of 3 quarters · filed 2026-07-30 | $30.54M 10-K · filed 2026-02-19 |
| 2025-09-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $9.69M derived: sum of 2 quarters · filed 2026-07-30 | $25.18M 10-Q · filed 2025-10-29 | $33.21M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $7.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $22.92M 10-Q · filed 2026-07-30 | $30.94M derived: sum of 3 quarters · filed 2026-07-30 | $33.81M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $15.50M 10-Q · filed 2026-05-07 | $23.52M derived: sum of 2 quarters · filed 2026-05-07 | $26.39M derived: sum of 3 quarters · filed 2026-05-07 | $29.63M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $8.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.90M derived: sum of 2 quarters · filed 2026-02-19 | $14.14M derived: sum of 3 quarters · filed 2026-02-19 | $15.68M 10-K · filed 2026-02-19 |
| 2024-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $6.11M derived: sum of 2 quarters · filed 2025-10-29 | $7.66M 10-Q · filed 2025-10-29 | $10.74M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $4.78M 10-Q · filed 2025-07-30 | $7.87M derived: sum of 3 quarters · filed 2026-02-19 | $10.87M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.54M 10-Q · filed 2025-04-30 | $4.63M derived: sum of 2 quarters · filed 2026-02-19 | $7.63M derived: sum of 3 quarters · filed 2026-02-19 | $11.75M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.09M derived: sum of 2 quarters · filed 2026-02-19 | $10.20M derived: sum of 3 quarters · filed 2026-02-19 | $11.20M 10-K · filed 2026-02-19 |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $7.12M derived: sum of 2 quarters · filed 2024-11-06 | $8.11M 10-Q · filed 2024-11-06 | $9.47M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.11M 10-Q · filed 2024-08-07 | $6.47M derived: sum of 3 quarters · filed 2025-02-20 | $10.81M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $993.00K 10-Q · filed 2024-05-09 | $2.35M derived: sum of 2 quarters · filed 2025-02-20 | $6.69M derived: sum of 3 quarters · filed 2025-02-20 | $7.91M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $5.70M derived: sum of 2 quarters · filed 2025-02-20 | $6.92M derived: sum of 3 quarters · filed 2025-02-20 | $7.88M 10-K · filed 2025-02-20 |
| 2022-09-30 | $4.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $5.56M derived: sum of 2 quarters · filed 2023-11-06 | $6.52M 10-Q · filed 2023-11-06 | $8.12M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.18M 10-Q · filed 2023-08-03 | $3.78M derived: sum of 3 quarters · filed 2024-02-22 | $10.98M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $957.00K 10-Q · filed 2023-05-09 | $2.56M derived: sum of 2 quarters · filed 2024-02-22 | $9.76M derived: sum of 3 quarters · filed 2024-02-22 | $11.14M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $8.80M derived: sum of 2 quarters · filed 2024-02-22 | $10.18M derived: sum of 3 quarters · filed 2024-02-22 | $83.76M 10-K · filed 2024-02-22 |
| 2021-09-30 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $8.58M derived: sum of 2 quarters · filed 2022-11-03 | $82.16M 10-Q · filed 2022-11-03 | $83.36M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $74.96M 10-Q · filed 2022-08-04 | $76.16M derived: sum of 3 quarters · filed 2023-02-23 | $78.41M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $73.58M 10-Q · filed 2022-05-05 | $74.78M derived: sum of 2 quarters · filed 2023-02-23 | $77.02M derived: sum of 3 quarters · filed 2023-02-23 | $77.02M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.45M derived: sum of 2 quarters · filed 2023-02-23 | $3.45M derived: sum of 3 quarters · filed 2023-02-23 | $3.45M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.25M derived: sum of 2 quarters · filed 2021-11-04 | $2.25M 10-Q · filed 2021-11-04 | $2.25M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |